Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
AMGN
Nasdaq
2836
www.amgen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amgen Inc.
Stock Market Election News: Dow Futures Reverse Higher, AMD, Arista Rally After Democrats Sweep; SpaceX, Tesla Are Losers (Live)
- Nov 4th, 2026 4:55 am
Amgen Inc (AMGN) (Q3 2026) Earnings Call Highlights: Revenue Up 8% to $10. ...
- Nov 3rd, 2026 10:12 pm
What Amgen (AMGN) Said on Its Q3 Earnings Call
- Nov 3rd, 2026 6:14 pm
Amgen (AMGN) Reports Q3 Earnings: What Key Metrics Have to Say
- Nov 3rd, 2026 3:30 pm
Amgen (NASDAQ:AMGN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
- Nov 3rd, 2026 3:14 pm
Amgen beats third quarter forecasts on top and bottom lines
- Nov 3rd, 2026 2:40 pm
Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.
- Nov 3rd, 2026 2:24 pm
Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates
- Nov 3rd, 2026 2:15 pm
Amgen: Q3 Earnings Snapshot
- Nov 3rd, 2026 2:12 pm
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
- Nov 3rd, 2026 2:01 pm
Amgen Stocks Move Lower Before Tonight's Earnings Report
- Nov 3rd, 2026 11:20 am
Is Wall Street Bullish or Bearish on Amgen Stock?
- Nov 3rd, 2026 7:18 am
Spdr Dow Jones Industrial Avg ETF (DIA) Sells Goldman Sachs and Caterpillar on Oct. 30
- Nov 3rd, 2026 4:05 am
Betting On Drug Sales: Is Viatris Or Lilly The Better Way In?
- Nov 2nd, 2026 1:21 pm
Amgen Just Gave Its Shareholders Great News
- Nov 2nd, 2026 10:45 am
Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?
- Nov 2nd, 2026 9:22 am
RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines
- Nov 2nd, 2026 8:50 am
Amgen (AMGN) Gets FDA Warning Letter Over Misleading Vectibix Promotion
- Nov 2nd, 2026 8:06 am
Scroll